Slo-bid

   
Google
 
Web NewDrugInformation.com

Slo-bid


Drug - Slo-bid
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Theophylline
Multiple ingredients are in alphabetical order.

Strength - 50MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.

Applicant - AVENTIS
The firm name holding legal responsibility for Slo-bid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088269
The FDA assigned number to Slo-bid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Slo-bid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 31, 1985
The date Slo-bid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Slo-bid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Slo-bid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Slo-bid.

Slo-bid